Evidence map›Paper›PMID 34769877›Full record

SynthesisInternational journal of environmental research and public health2021

Value of Active Warming Devices for Intraoperative Hypothermia Prevention-A Meta-Analysis and Cost-Benefit Analysis.

He Xu, Zijing Wang, Yijuan Lu, Xin Guan, Yue Ma, Daniel C Malone, Jack Warren Salmon, Aixia Ma, Wenxi Tang

Abstract readMeta-Analysis
In one paragraph

Synthesis in International journal of environmental research and public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

He XuSchool of International Pharmaceutical Business, China Pharmaceutical University, No. 639 Longmian Street, Nanjing 211198, China.
Zijing WangSchool of International Pharmaceutical Business, China Pharmaceutical University, No. 639 Longmian Street, Nanjing 211198, China.
Yijuan LuSchool of International Pharmaceutical Business, China Pharmaceutical University, No. 639 Longmian Street, Nanjing 211198, China.
Xin GuanSchool of International Pharmaceutical Business, China Pharmaceutical University, No. 639 Longmian Street, Nanjing 211198, China.
Yue MaSchool of International Pharmaceutical Business, China Pharmaceutical University, No. 639 Longmian Street, Nanjing 211198, China.
Daniel C MaloneCollege of Pharmacy, University of Utah, Salt Lake City, UT 84101, USA.
Jack Warren SalmonCollege of Pharmacy, University of Illinois Chicago, 833 South Wood Street, Chicago, IL 60612, USA.
Aixia MaSchool of International Pharmaceutical Business, China Pharmaceutical University, No. 639 Longmian Street, Nanjing 211198, China.
Wenxi TangSchool of International Pharmaceutical Business, China Pharmaceutical University, No. 639 Longmian Street, Nanjing 211198, China.ORCID 0000-0002-3564-3626

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeHistorically, studies suggested that intraoperative hypothermia (IH) could result in significant resource consumption, but more recent studies have found the opposite. The purpose of this study is to estimate the value of active warming devices for IH prevention based on synthesized evidence.

methodsA cost-benefit analysis was conducted using the effect of active warming versus passive warming devices for intraoperative hypothermia from a meta-analysis. The item-based aggregated treatment cost approach was adopted to estimate the cost of each adverse event, which was then weighted to calculate the total cost of IH.

resultsIH was associated with higher risks of bleeding, surgical site infection, and shivering compared with normothermia. The cost of one case of IH was $363.80, and the use of active warming devices might save $152.80. Extra investment in active warming (e.g., $291.00) might only be cost-beneficial when the minimum willingness-to-pay is $150.00.

conclusionsSynthesized evidence showed that the cost of IH might be overestimated. Furthermore, the value of using active warming devices remains uncertain because the willingness to pay may vary between decision-makers. As not enough awareness of hypothermia prevention in some countries, further research into the clinical use of active warming devices during major surgeries is warranted.

Indexed as

HypothermiaBody TemperatureCost-Benefit AnalysisHemorrhageHumansShiveringSurgical Wound Infectionactive warming devicescost-benefit analysisintraoperative hypothermiameta-analysis

Identifiers

PMID34769877
PMCPMC8582721

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.